One year outcomes of treat and extend and pro re nata (PRN) treatment regimens with aflibercept for polypoidal choroidal vasculopathy

CONCLUSION: We highlighted the superiority of treat-and-extend regime with IAIs, which seems to yield better functional outcomes by preventing recurrence and subfoveal fibrosis, although a greater number of injections is required.PMID:33951982 | DOI:10.1177/11206721211014717

Source: European Journal of Ophthalmology - May 6, 2021 Category: Opthalmology Authors: Alexandros Rouvas Nikolaos Gouliopoulos Maria Douvali Georgios Koutsocheras Maria Theodorou Nikolaos Bouratzis Panagiota Bougatsou Panagiotis Theodossiadis Source Type: research